Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart drug shows promise for chinese patients with thick heart muscle

NCT ID NCT06116968

First seen Jan 22, 2026 · Last updated May 20, 2026 · Updated 21 times

Summary

This study tested a drug called aficamten in 40 Chinese adults with a heart condition that makes the heart muscle too thick and blocks blood flow. The goal was to see if the drug is safe and helps the heart pump better over time. Participants had already completed a previous study of the same drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Beijing Anzhen Hospital

    Beijing, China

  • Beijing Chao-yang Hospital, Capital Medical University

    Beijing, China

  • Fuwai Hospital, CAMS & PUMC

    Beijing, China

  • Nanfang Hospital

    Guangzhou, China

  • Peking University Third Hospital

    Beijing, China

  • Shengjing Hospital of China Medical University

    Shenyang, China

  • Sichuan Provincial People's Hospital

    Chengdu, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, China

  • The First Hospital of Jilin University

    Jilin, China

  • The Second Affiliated Hospital of Nanchang University

    Jiangxi, China

  • Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, China

Conditions

Explore the condition pages connected to this study.